A comparative assessment of three formulations of botulinum toxin A for facial rhytides: a systematic review and meta-analyses: Bonaparte JP et al.

Background: Botulinum toxin type A is a commonly used biological medication for a variety of medical and cosmetic indications. Currently, there are three commonly used formulations of botulinum toxin A: onabotulinum toxin A (Botox or Vistabel (Allergen, Irvine, CA, USA), incobotulinumtoxin A (Xeomin or Bocouture (Merz Pharmaceuticals, Frankfurt, Germany), and abobotulinum toxin A (Dysport (Medicis, Scottsdale, AZ, USA) or Azzalure (Ipsen, Paris,France). …

Bonaparte et al. Systematic Reviews  2013,  2:40
http://www.systematicreviewsjournal.com/content/2/1/40

 
Autoren:
James P Bonaparte   1,2,3,5*,
David Ellis   1,2,5,
Jason G Quinn   
3,
Mohammed T Ansari   
4,
Jessica Rabski   
1,2
and Shaun J Kilty   3
  
 
 
Autoren-Details:
1  Department of Otolaryngology – Head and Neck Surgery, The University of  Toronto, Toronto, ON M5G 2N2, Canada
2  Division of Facial Plastic and Reconstructive Surgery, The University of  Toronto, Toronto, ON M5G 1L5, Canada Full list of author information is available at the end of the article